ACS Sensors · 2016 · 38 citations · 47 references
EngineeringBioengineeringBiomedical EngineeringBiomaterialsBiosensorsElectroanalytical MethodsAptamer-based BiosensorsLigand BindingMolecular SensorsNanomaterial-based BiosensorsNanomedicineAntifouling SurfacesAptamer ImmobilizationChemical Surface FunctionalizationCovalent ImmobilizationCovalent Surface ModificationProtein DetectionSquare-wave VoltammetryVoltammetry
We report the development of a simple surface chemistry strategy for the construction of sensitive aptasensors on a polypyrrole (PPy)–polyethylene glycol (PEG) platform in order to provide enhanced antifouling properties. We report the covalent modification of a PPy film formed on a gold electrode by PEG molecules, without prior chemical functionalization of the pyrrole monomer. This process was mediated by electro-oxidation of amine groups present on the one of the PEG end chains. Polyhistidine modified aptamers were immobilized to this surface via a N α, N α-Bis(carboxymethyl)- l -lysine ANTA/Cu 2+ redox complex covalently attached to the PPy-PEG adduct. The fabricated aptasensor was then utilized for the detection of α-methylacyl-CoA racemase (AMACR; P504S), an emerging biomarker for prostate cancer. Protein/aptamer interactions were monitored through variation of the copper redox signal, using the square wave voltammetry (SWV) technique. We demonstrate that the PPy-PEG-ANTA/Cu 2+ hybrid material is characterized by enhanced antifouling properties and sensitivity. The aptasensor was able to detect AMACR down to 5 fM in both buffer and spiked human plasma with a limit of detection (LOD) of 0.15 fM and 1.4 fM, respectively. The developed aptasensor can be generalized for use with any type of aptamer-based sensor.
47
Limit of blank, limit of detection and limit of quantitation.
David Armbruster, Terry Pry · PubMed · 2008 · 2.1K citations · Full text
α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Mark A. Rubin · JAMA · 2002 · 646 citations
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Patrick C. Walsh · PubMed · 2002 · 477 citations